PRESCRIPTION DRUG COSTS +++

PRESCRIPTION DRUG COSTS NBC News: White House Expands TrumpRx With Three New Drugs https://www.nbcnews.com/health/health-news/white-house-expands-trumprx-three-new-drugs-rcna264500?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-8VpZugDBu87OwdOFWp7GdiMXuOjmaayapvcds7W3-M1ZcVuvcsZqlMGHbetCSvWQZ8MJSemH0r_cHURFYO5Vitct07tw&_hsmi=410057768&utm_content=410057768&utm_source=hs_email The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the administration works to expand the site as part of its push to lower drug prices. The drugs, from German drugmaker Boehringer Ingelheim, are Jentadueto and Jentadueto XR, for Type 2 diabetes, as well as the COPD drug Striverdi Respimat. (Lovelace Jr., 3/20) Stat: Iran War Has Not Disrupted Pharma Supply Chains. That Could Change If Conflict Is Prolonged https://www.statnews.com/pharmalot/2026/03/20/iran-war-impact-pharma-supply-chain/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz--kn4UHooTPQ5rEJczkex65683W4gwQ9GCJ0zk43NwX06l4AWbhoSKtcR0KFM-1aDfK5kJu_4R1wEFTejy3iIsX_ojDJQ&_hsmi=410057768&utm_content=410057768&utm_source=hs_email The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but with no clear end in sight, the potential exists for the conflict to change the calculus for production, shipping, and, ultimately, pricing for different medicines in different countries, according to industry experts. (Silverman and Merelli, 3/20) The Wall Street Journal: RFK Jr. Wants To End The ‘War On Peptides’ And Make The Chinese Drugs Legal And Easier To Buy https://www.wsj.com/health/rfk-jr-china-peptides-market-2ce249df?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-_KAJjmp9gZaRXmvFEU78qjdp07Zp45CnEzyh7Tu8oTaC4ZHQAqmHhYr18AYtgFGDEwsLT9dMj553c7vgmMDjYJkfYseQ&_hsmi=410057768&utm_content=410057768&utm_source=hs_email The substances, manufactured in China, come in tiny glass bottles with names like “Glow Stack” and “Wolverine Stack.” They promise youthful skin and speedy muscle recovery, delivered in injectable form. Influencers, celebrities and everyday people are raving about peptides, unapproved drugs driving a gray-market craze. And they now have an ally in Health and Human Services Secretary Robert F. Kennedy Jr., who wants to make peptides easier—and legal—to buy. (Siddiqui and O'Brien, 3/22)